Level C· Early human research exploring benefitsProspective StudyPubMed

[Application of adipose-derived mesenchymal stem cells in craniomaxillofacial restoration and reconstruction].

Shu M., Liu L.

Prospective Study on Face & Skin, published in Hua Xi Kou Qiang Yi Xue Za Zhi (2013) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Hua Xi Kou Qiang Yi Xue Za Zhi (2013)
Country
China
Reported sample size
—
Source database
PubMed
PMID
24437306
Citations
1

Abstract (original English)

Craniomaxillofacial hard and soft tissue defects are clinically common and frequently encountered diseases that seriously affect the appearance and function of patients. Restoration and reconstruction of craniomaxillofacial hard and soft tissues are comprehensive clinical problems that require a multi-disciplinary approach and are faced with many unresolved issues. Development of tissue engineering has introduced new concepts to craniomaxillofacial restoration and reconstruction. Tissue engineering primarily aims to determine suitable seed cells. Recently, adipose-derived mesenchymal stem cells (AdSCs) were found to be relatively ideal seed cells because they are easy to obtain from numerous sources and have multiple potencies under certain inducing circumstances and high augmenting ability. This review provides an overview of the application of AdSCs in craniomaxillofacial restoration and reconstruction.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
Adipose TissueHumansMesenchymal Stem CellsPlastic Surgery ProceduresTissue Engineering

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research